Continuing Research and Development Activities
First written in FY2016-Q3. 26 of 30 entries say "Restated". Latest entry: FY2025-H1.
99 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「Total research and development expenses for the six-month interim consolidated period were ¥87.56 million. There were no material changes in the status of the Group's research and development activities during the six-month interim consolidated period.」
The company reconfirmed that there were no material changes to its research and development activities and reported research and development expenses of ¥87.56 million for the six-month interim consolidated period. - FY2024-Q2RestatedAnnual report
「Total research and development expenses for the six-month period ended 30 September were ¥98.3 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended 30 September.」
The company reconfirmed that there were no material changes to its research and development activities and recorded research and development expenses of ¥98.3 million. - FY2023-Q3RestatedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥145.187 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended 31 December.」
The company reconfirmed that there were no material changes to its research and development activities and reported research and development expenses of ¥145.187 million for the nine-month period ended 31 December. - FY2023-Q2RestatedAnnual report
「Total research and development expenses for the six-month period ended 30 September were ¥94.105 million. There were no material changes in the status of the Group's research and development activities during the six-month period ended 30 September.」
The company reconfirmed that there were no material changes to its research and development activities and recorded research and development expenses of ¥94.105 million. - FY2023-Q1RestatedAnnual report
「Total research and development expenses for the three-month period ended 30 June were ¥54.683 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended 30 June.」
The company reconfirmed that there were no material changes to its research and development activities and reported research and development expenses of ¥54.683 million for the three-month period ended 30 June. - FY2022AdvancedAnnual report
「Total research and development expenses for the fiscal year were ¥213.097 million, relating to industrial plastic fasteners and precision plastic components. The research and development activities and principal results are as follows.」
Research and development expenses increased from ¥185.393 million in the previous fiscal year to ¥213.097 million. The company describes performance evaluations of NIXAM materials, insect-repellent materials, and the continued development and product adoption of heat-resistant sliding components made from NIXAM. - FY2022-Q3RestatedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥160.425 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended 31 December.」
The company reconfirmed that there were no material changes to its research and development activities and recorded research and development expenses of ¥160.425 million. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal period were ¥102.858 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal period.」
The company reconfirmed that there were no material changes to its research and development activities and recorded research and development expenses of ¥102.858 million. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal period were ¥58.993 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal period.」
The company reaffirmed that there had been no significant changes in its R&D activities and disclosed R&D expenses of ¥58.993 million for the cumulative first quarter of the consolidated fiscal period. - FY2021AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥185.393 million, relating to industrial plastic fasteners and precision plastic parts. The R&D activities and principal results were as follows.」
R&D expenses increased from ¥168.954 million in the previous fiscal year to ¥185.393 million. Centered on the R&D Center, the company is conducting performance evaluations of NIXAM materials and continuing the development and adoption of NIXAM heat-resistant sliding parts. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal period were ¥142.715 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥142.715 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal period were ¥85.007 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥85.007 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal period were ¥46.294 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥46.294 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2020RestatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥168.954 million, relating to industrial plastic fasteners and precision plastic parts,」
The company described its R&D structure centered on the R&D Center, ongoing research into NIXAM materials and heat-resistant sliding parts, and R&D expenses of ¥168.954 million. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal period were ¥132.680 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥132.680 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal period were ¥90.579 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥90.579 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal period were ¥52.905 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥52.905 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal period were ¥167.174 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥167.174 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal period were ¥107.806 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥107.806 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal period were ¥65.127 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal period.」
The company recorded R&D expenses of ¥65.127 million and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2018RestatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥220.496 million, relating to industrial plastic fasteners and precision plastic parts,」
The company described R&D expenses of ¥220.496 million, its R&D structure centered on the R&D Center, and ongoing research and adoption results for NIXAM materials and heat-resistant sliding parts. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal period were ¥176.202 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal period.」
The company disclosed total R&D expenses and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal period were ¥109.707 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal period.」
The company disclosed total R&D expenses and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal period were ¥63.051 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal period.」
The company disclosed total R&D expenses and reaffirmed that there had been no significant changes in the status of its R&D activities. - FY2017AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥214.149 million, relating to industrial plastic fasteners and precision plastic parts. The R&D activities and principal results were as follows.」
R&D expenses increased to ¥214.149 million. The company described the adoption of its development materials for insect screens and the adoption of NIXAM heat-resistant sliding parts by major office equipment manufacturers and others. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal period were ¥166.448 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal period.」
The company reaffirmed that there had been no significant changes in its R&D activities and disclosed total R&D expenses for the cumulative third quarter. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal period were ¥105.325 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter of the consolidated fiscal period.」
The company reaffirmed that there had been no significant changes in its R&D activities and disclosed total R&D expenses for the cumulative second quarter of the consolidated fiscal period. - FY2017-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal period were ¥61.407 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter of the consolidated fiscal period.」
The company reaffirmed that there had been no significant changes in its R&D activities and disclosed total R&D expenses for the quarter. - FY2016RestatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥189.487 million, relating to industrial plastic fasteners and precision plastic parts. The R&D activities and principal results were as follows.」
The company described its R&D structure centered on the R&D Center, ongoing research into NIXAM materials and heat-resistant sliding parts, and total R&D expenses. - FY2016-Q3First statedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal period were ¥145.285 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter of the consolidated fiscal period.」
The company stated that there had been no significant changes in its R&D activities and disclosed total R&D expenses for the cumulative period.